328 related articles for article (PubMed ID: 33982017)
1. Generation of a squamous cell carcinoma mouse model for lineage tracing of BMI1+ cancer stem cells.
Chen D; Zhang W; Jia L; Wang C; Wang CY
STAR Protoc; 2021 Jun; 2(2):100484. PubMed ID: 33982017
[TBL] [Abstract][Full Text] [Related]
2. Targeting BMI1
Chen D; Wu M; Li Y; Chang I; Yuan Q; Ekimyan-Salvo M; Deng P; Yu B; Yu Y; Dong J; Szymanski JM; Ramadoss S; Li J; Wang CY
Cell Stem Cell; 2017 May; 20(5):621-634.e6. PubMed ID: 28285905
[TBL] [Abstract][Full Text] [Related]
3. METTL3-mediated ALDH m
Chen Z; Chen J; Xu X; Li Q; Zhang C; Li S; Liu L; Cao C; Chen D; He Q
Oral Dis; 2024 Apr; 30(3):1061-1071. PubMed ID: 37249063
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
5. SOX18 meditates the resistance of Bmi1-expressing cells to cetuximab in HNSCC.
Zhang C; Chen Z; Gao N; Xiong G; Chen P; Li H; Chen D; He Q; Peng L
Oral Dis; 2024 Apr; 30(3):1100-1113. PubMed ID: 37184032
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional super-enhancers control cancer stemness and metastasis genes in squamous cell carcinoma.
Dong J; Li J; Li Y; Ma Z; Yu Y; Wang CY
Nat Commun; 2021 Jun; 12(1):3974. PubMed ID: 34172737
[TBL] [Abstract][Full Text] [Related]
7. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
[TBL] [Abstract][Full Text] [Related]
8. Doxycycline-induced exogenous Bmi-1 expression enhances tumor formation in a murine model of oral squamous cell carcinoma.
Kalish JM; Tang XH; Scognamiglio T; Zhang T; Gudas LJ
Cancer Biol Ther; 2020 May; 21(5):400-411. PubMed ID: 32037955
[TBL] [Abstract][Full Text] [Related]
9. CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.
Ganguli-Indra G; Wasylyk C; Liang X; Millon R; Leid M; Wasylyk B; Abecassis J; Indra AK
PLoS One; 2009; 4(4):e5367. PubMed ID: 19399189
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma.
Chen X; Cao Y; Sedhom W; Lu L; Liu Y; Wang H; Oka M; Bornstein S; Said S; Song J; Lu SL
Mol Oncol; 2020 Jan; 14(1):139-158. PubMed ID: 31600013
[TBL] [Abstract][Full Text] [Related]
11. The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cells.
Herzog AE; Warner KA; Zhang Z; Bellile E; Bhagat MA; Castilho RM; Wolf GT; Polverini PJ; Pearson AT; Nör JE
Cell Death Dis; 2021 Oct; 12(11):988. PubMed ID: 34689150
[TBL] [Abstract][Full Text] [Related]
12. Joining Forces: Bmi1 Inhibition and Cisplatin Curb Squamous Carcinogenesis.
Brown JA; Schober M
Cell Stem Cell; 2017 May; 20(5):575-577. PubMed ID: 28475877
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
[TBL] [Abstract][Full Text] [Related]
14. BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse.
Jia L; Zhang W; Wang CY
Cell Stem Cell; 2020 Aug; 27(2):238-253.e6. PubMed ID: 32697949
[TBL] [Abstract][Full Text] [Related]
15. SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma.
Wu Y; Hu H; Zhang W; Li Z; Diao P; Wang D; Zhang W; Wang Y; Yang J; Cheng J
J Cell Mol Med; 2018 Jul; 22(7):3582-3594. PubMed ID: 29667751
[TBL] [Abstract][Full Text] [Related]
16. FOXA1-induced LINC01207 facilitates head and neck squamous cell carcinoma via up-regulation of TNRC6B.
Chen C; Jiang L; Zhang Y; Zheng W
Biomed Pharmacother; 2020 Aug; 128():110220. PubMed ID: 32450521
[TBL] [Abstract][Full Text] [Related]
17. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
[TBL] [Abstract][Full Text] [Related]
18. Bmi1-positive cells in the lingual epithelium could serve as cancer stem cells in tongue cancer.
Tanaka T; Atsumi N; Nakamura N; Yanai H; Komai Y; Omachi T; Tanaka K; Ishigaki K; Saiga K; Ohsugi H; Tokuyama Y; Imahashi Y; Hisha H; Yoshida N; Kumano K; Okazaki K; Ueno H
Sci Rep; 2016 Dec; 6():39386. PubMed ID: 28004815
[TBL] [Abstract][Full Text] [Related]
19. CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance.
Wang C; Li Y; Jia L; Kim JK; Li J; Deng P; Zhang W; Krebsbach PH; Wang CY
Cell Stem Cell; 2021 Sep; 28(9):1597-1613.e7. PubMed ID: 33945793
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblast-derived extracellular vesicles promote lymph node metastases in oral cavity squamous cell carcinoma by encapsulating ITGB1 and BMI1.
Lv T; Liu H; Mao L; Song Y; Liao L; Zhong K; Shuai B; Luo Y; Guo T; Huang W; Zhang S
BMC Cancer; 2024 Jan; 24(1):113. PubMed ID: 38254031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
